Tirzepatide injection
From Original price was: $263.00.$223.00Current price is: $223.00. / Month
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist designed to manage type 2 diabetes and promote weight loss. By activating both GIP and GLP-1 receptors, it enhances insulin secretion, reduces glucagon levels, slows gastric emptying, and suppresses appetite, leading to improved blood sugar control and significant weight reduction. Administered as a once-weekly subcutaneous injection (marketed as Mounjaro or Zepbound), tirzepatide has shown superior efficacy compared to other GLP-1 agonists in clinical trials, also lowering cardiovascular risk factors. It’s prescribed for adults with type 2 diabetes or obesity, alongside diet and exercise, to support metabolic health and sustainable weight management.